Upgrade to SI Premium - Free Trial

Pharvaris (PHVS)

34.17 +0.91 (2.74%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/19/26)

Latest Headlines

Pharvaris publishes review on bradykinin B2 receptor as therapy target July 22, 2026 6:50 AM - StreetInsider Publication in Clinical Reviews in Allergy & Immunology Summarizes Decades of Evidence Supporting Bradykinin B2 Receptor as a Validated Therapeutic Target in Bradykinin-Mediated Angioedema July 22, 2026 6:50 AM - Globe NewsWire Publication in Clinical Reviews in Allergy & Immunology Summarizes Decades of Evidence Supporting Bradykinin B2 Receptor as a Validated Therapeutic Target in Bradykinin-Mediated Angioedema July 22, 2026 6:50 AM - StreetInsider Form 4 Pharvaris N.V. For: Jul 13 Filed by: Modig Berndt July 15, 2026 1:08 PM - SEC Filing Wells Fargo Starts Pharvaris B.V. (PHVS) at Overweight July 15, 2026 5:11 AM - StreetInsider Form 4 Pharvaris N.V. For: Jul 11 Filed by: Lu Peng July 14, 2026 3:47 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Modig Berndt July 13, 2026 4:39 PM - SEC Filing FDA accepts Pharvaris NDA for oral HAE attack treatment deucrictibant July 6, 2026 6:50 AM - StreetInsider Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks July 6, 2026 6:50 AM - StreetInsider Form 4 Pharvaris N.V. For: Jun 29 Filed by: Schikan Johannes Gerardus Christiaan Petrus July 1, 2026 7:06 PM - SEC Filing Form 4 Pharvaris N.V. For: Jun 29 Filed by: Lesage Anne July 1, 2026 7:03 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Lesage Anne June 30, 2026 4:37 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Lesage Anne June 30, 2026 4:37 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Schikan Johannes Gerardus Christiaan Petrus June 30, 2026 4:36 PM - SEC Filing Form 4 Pharvaris N.V. For: Jun 25 Filed by: Lesage Anne June 29, 2026 6:41 PM - SEC Filing Form 4 Pharvaris N.V. For: Jun 29 Filed by: Schikan Johannes Gerardus Christiaan Petrus June 29, 2026 6:18 PM - SEC Filing Form 4 Pharvaris N.V. For: Jun 25 Filed by: Lu Peng June 29, 2026 6:18 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Schikan Johannes Gerardus Christiaan Petrus June 29, 2026 4:49 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Lesage Anne June 29, 2026 4:46 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Lesage Anne June 29, 2026 4:46 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Lu Peng June 26, 2026 4:31 PM - SEC Filing Form 6-K Pharvaris N.V. For: Jun 26 June 26, 2026 11:27 AM - SEC Filing Form 144 Pharvaris N.V. Filed by: Lu Peng June 25, 2026 4:25 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Lesage Anne June 25, 2026 4:24 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Lesage Anne June 25, 2026 4:24 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Schikan Johannes Gerardus Christiaan Petrus June 25, 2026 4:24 PM - SEC Filing Pharvaris B.V. (PHVS) PT Raised to $46 at Morgan Stanley June 25, 2026 8:53 AM - StreetInsider Form 4 Pharvaris N.V. For: Jun 18 Filed by: Lu Peng June 23, 2026 5:07 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Lu Peng June 18, 2026 4:28 PM - SEC Filing Form 4 Pharvaris N.V. For: Jun 17 Filed by: Modig Berndt June 17, 2026 5:52 PM - SEC Filing Form 4 Pharvaris N.V. For: Jun 12 Filed by: Lu Peng June 16, 2026 5:50 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Pharvaris B.V. (PHVS) June 16, 2026 6:44 AM - StreetInsider Form 4 Pharvaris N.V. For: Jun 11 Filed by: Lu Peng June 15, 2026 5:23 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Modig Berndt June 15, 2026 4:55 PM - SEC Filing Pharvaris presents data on deucrictibant for hereditary angioedema treatment June 15, 2026 6:50 AM - StreetInsider Data Supporting Differentiated Profile of Deucrictibant in HAE Management Presented at EAACI 2026 June 15, 2026 6:50 AM - StreetInsider Form 6-K Pharvaris N.V. For: Jun 11 June 11, 2026 6:52 AM - SEC Filing Pharvaris Announces Annual General Meeting of Shareholders June 11, 2026 6:50 AM - StreetInsider Form 4 Pharvaris N.V. For: Jun 04 Filed by: Nijdam Anna June 8, 2026 2:54 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Nijdam Anna June 4, 2026 6:22 PM - SEC Filing Pharvaris to Present Clinical Data at the EAACI Annual Congress 2026 May 29, 2026 6:50 AM - Globe NewsWire Form 4 Pharvaris N.V. For: May 21 Filed by: Monges Viviane May 26, 2026 5:54 PM - SEC Filing Form 4 Pharvaris N.V. For: May 21 Filed by: Nijdam Anna May 26, 2026 5:45 PM - SEC Filing Form 4 Pharvaris N.V. For: May 21 Filed by: Nassif David W. May 26, 2026 5:42 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Nijdam Anna May 22, 2026 5:03 PM - SEC Filing Form 4 Pharvaris N.V. For: May 20 Filed by: Bjork Elisabeth May 22, 2026 2:54 PM - SEC Filing Form 4/A Pharvaris N.V. For: May 18 Filed by: Modig Berndt May 22, 2026 2:41 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Nijdam Anna May 21, 2026 5:36 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Monges Viviane May 21, 2026 5:31 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Nassif David W. May 21, 2026 5:27 PM - SEC Filing Form 4 Pharvaris N.V. For: May 18 Filed by: Modig Berndt May 20, 2026 5:34 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Bjork Elisabeth May 20, 2026 5:24 PM - SEC Filing Form 144/A Pharvaris N.V. Filed by: Glassman Robert May 20, 2026 4:31 PM - SEC Filing Form 4 Pharvaris N.V. For: May 15 Filed by: Glassman Robert May 19, 2026 6:48 PM - SEC Filing Form 4 Pharvaris N.V. For: May 15 Filed by: Abele Stefan Andreas May 19, 2026 6:45 PM - SEC Filing Form 4 Pharvaris N.V. For: May 15 Filed by: Souverijns Wim May 19, 2026 6:43 PM - SEC Filing Form SCHEDULE 13G/A Pharvaris N.V. Filed by: VIKING GLOBAL INVESTORS LP May 15, 2026 5:51 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Abele Stefan Andreas May 15, 2026 5:51 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Souverijns Wim May 15, 2026 5:45 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Modig Berndt May 15, 2026 4:36 PM - SEC Filing Form 144 Pharvaris N.V. Filed by: Glassman Robert May 15, 2026 4:19 PM - SEC Filing Form 4 Pharvaris N.V. For: May 11 Filed by: Lu Peng May 13, 2026 6:49 PM - SEC Filing Pharvaris B.V. (PHVS) PT Lowered to $74 at Citizens Ahead of Phase 3 Readout in Q3 May 13, 2026 5:10 AM - StreetInsider Form 6-K Pharvaris N.V. For: May 12 May 12, 2026 4:05 PM - SEC Filing Pharvaris Reports First Quarter 2026 Financial Results and Provides Business Update May 12, 2026 4:05 PM - StreetInsider Form 6-K Pharvaris N.V. For: May 11 May 11, 2026 4:42 PM - SEC Filing Form 424B5 Pharvaris N.V. May 8, 2026 5:13 PM - SEC Filing Pharvaris prices $115 million share offering at $29.68 per share May 8, 2026 6:01 AM - StreetInsider Pharvaris Announces Pricing of $115 Million Underwritten Offering of Ordinary Shares May 8, 2026 6:00 AM - Globe NewsWire Form 4 Pharvaris N.V. For: May 01 Filed by: Lu Peng May 5, 2026 3:51 PM - SEC Filing Form 4 Pharvaris N.V. For: Apr 29 Filed by: Schikan Johannes Gerardus Christiaan Petrus May 1, 2026 7:33 PM - SEC Filing Form 4 Pharvaris N.V. For: Apr 29 Filed by: Lesage Anne May 1, 2026 7:31 PM - SEC Filing Form 4 Pharvaris N.V. For: Apr 29 Filed by: Lu Peng May 1, 2026 7:10 PM - SEC Filing Full Article List